Connection

THOMAS A BUCHHOLZ to Pyrimidines

This is a "connection" page, showing publications THOMAS A BUCHHOLZ has written about Pyrimidines.
Connection Strength

0.101
  1. MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Oncotarget. 2016 11 01; 7(44):71660-71672.
    View in: PubMed
    Score: 0.060
  2. MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Clin Cancer Res. 2011 Sep 01; 17(17):5638-48.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.